APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Marburg Hemorrhagic Fever Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Marburg Hemorrhagic Fever Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025182 pages

Choose your research edition.

Industry ResearchMarburg Hemorrhagic Fever Drug Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Marburg Hemorrhagic Fever Drug Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Marburg Hemorrhagic Fever Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Marburg Hemorrhagic Fever Drug Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Marburg Hemorrhagic Fever Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Marburg Hemorrhagic Fever Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Marburg Hemorrhagic Fever Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Marburg Hemorrhagic Fever Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Marburg Hemorrhagic Fever Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Marburg Hemorrhagic Fever Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Marburg Hemorrhagic Fever Drug include GlaxoSmithKline plc, Vaxart, Inc, Tekmira Pharmaceuticals Corp., Sarepta Therapeutics, Inc., Integrated BioTherapeutics, Inc. and Immunovaccine, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Marburg Hemorrhagic Fever Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Marburg Hemorrhagic Fever Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Marburg Hemorrhagic Fever Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Marburg Hemorrhagic Fever Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Marburg Hemorrhagic Fever Drug Segment by Company

GlaxoSmithKline plc

Vaxart, Inc

Tekmira Pharmaceuticals Corp.

Sarepta Therapeutics, Inc.

Integrated BioTherapeutics, Inc.

Immunovaccine, Inc.

Marburg Hemorrhagic Fever Drug Segment by Type

TKM-Marburg

Marburg Vaccine

AVI-7288

Others

Marburg Hemorrhagic Fever Drug Segment by Application

Clinic

Hospital

Others

Marburg Hemorrhagic Fever Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Marburg Hemorrhagic Fever Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Marburg Hemorrhagic Fever Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Marburg Hemorrhagic Fever Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Marburg Hemorrhagic Fever Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Marburg Hemorrhagic Fever Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Marburg Hemorrhagic Fever Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Marburg Hemorrhagic Fever Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Marburg Hemorrhagic Fever Drug Industry Trends Table 2. Marburg Hemorrhagic Fever Drug Industry Drivers Table 3. Marburg Hemorrhagic Fever Drug Industry Opportunities and Challenges Table 4. Marburg Hemorrhagic Fever Drug Industry Restraints Table 5. Global Marburg Hemorrhagic Fever Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Marburg Hemorrhagic Fever Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Marburg Hemorrhagic Fever Drug Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Marburg Hemorrhagic Fever Drug Sales Market Share by Manufacturers Table 9. Global Marburg Hemorrhagic Fever Drug Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Marburg Hemorrhagic Fever Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Marburg Hemorrhagic Fever Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Marburg Hemorrhagic Fever Drug Manufacturers, Product Type & Application Table 13. Global Marburg Hemorrhagic Fever Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Marburg Hemorrhagic Fever Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of TKM-Marburg Table 17. Major Manufacturers of Marburg Vaccine Table 18. Major Manufacturers of AVI-7288 Table 19. Major Manufacturers of Others Table 20. Global Marburg Hemorrhagic Fever Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Marburg Hemorrhagic Fever Drug Sales by Type (2021-2026) & (K Units) Table 22. Global Marburg Hemorrhagic Fever Drug Sales by Type (2027-2032) & (K Units) Table 23. Global Marburg Hemorrhagic Fever Drug Sales Market Share by Type (2021-2026) Table 24. Global Marburg Hemorrhagic Fever Drug Sales Market Share by Type (2027-2032) Table 25. Global Marburg Hemorrhagic Fever Drug Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Marburg Hemorrhagic Fever Drug Revenue by Type (2021-2026) & (K Units) Table 27. Global Marburg Hemorrhagic Fever Drug Revenue by Type (2027-2032) & (K Units) Table 28. Global Marburg Hemorrhagic Fever Drug Revenue Market Share by Type (2021-2026) Table 29. Global Marburg Hemorrhagic Fever Drug Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Clinic Table 31. Major Manufacturers of Hospital Table 32. Major Manufacturers of Others Table 33. Global Marburg Hemorrhagic Fever Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Marburg Hemorrhagic Fever Drug Sales by Application (2021-2026) & (K Units) Table 35. Global Marburg Hemorrhagic Fever Drug Sales by Application (2027-2032) & (K Units) Table 36. Global Marburg Hemorrhagic Fever Drug Sales Market Share by Application (2021-2026) Table 37. Global Marburg Hemorrhagic Fever Drug Sales Market Share by Application (2027-2032) Table 38. Global Marburg Hemorrhagic Fever Drug Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Marburg Hemorrhagic Fever Drug Revenue by Application (2021-2026) & (K Units) Table 40. Global Marburg Hemorrhagic Fever Drug Revenue by Application (2027-2032) & (K Units) Table 41. Global Marburg Hemorrhagic Fever Drug Revenue Market Share by Application (2021-2026) Table 42. Global Marburg Hemorrhagic Fever Drug Revenue Market Share by Application (2027-2032) Table 43. Global Marburg Hemorrhagic Fever Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Marburg Hemorrhagic Fever Drug Sales by Region (2021-2026) & (K Units) Table 45. Global Marburg Hemorrhagic Fever Drug Sales Market Share by Region (2021-2026) Table 46. Global Marburg Hemorrhagic Fever Drug Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Marburg Hemorrhagic Fever Drug Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Marburg Hemorrhagic Fever Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Marburg Hemorrhagic Fever Drug Sales by Country (2021-2026) & (K Units) Table 50. North America Marburg Hemorrhagic Fever Drug Sales by Country (2027-2032) & (K Units) Table 51. Europe Marburg Hemorrhagic Fever Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Marburg Hemorrhagic Fever Drug Sales by Country (2021-2026) & (K Units) Table 53. Europe Marburg Hemorrhagic Fever Drug Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Marburg Hemorrhagic Fever Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Marburg Hemorrhagic Fever Drug Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Marburg Hemorrhagic Fever Drug Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Marburg Hemorrhagic Fever Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Marburg Hemorrhagic Fever Drug Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Marburg Hemorrhagic Fever Drug Sales by Country (2027-2032) & (K Units) Table 60. Global Marburg Hemorrhagic Fever Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Marburg Hemorrhagic Fever Drug Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Marburg Hemorrhagic Fever Drug Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Marburg Hemorrhagic Fever Drug Revenue Market Share by Region (2021-2026) Table 64. Global Marburg Hemorrhagic Fever Drug Revenue Market Share by Region (2027-2032) Table 65. GlaxoSmithKline plc Company Information Table 66. GlaxoSmithKline plc Business Overview Table 67. GlaxoSmithKline plc Marburg Hemorrhagic Fever Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. GlaxoSmithKline plc Marburg Hemorrhagic Fever Drug Product Portfolio Table 69. GlaxoSmithKline plc Recent Development Table 70. Vaxart, Inc Company Information Table 71. Vaxart, Inc Business Overview Table 72. Vaxart, Inc Marburg Hemorrhagic Fever Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Vaxart, Inc Marburg Hemorrhagic Fever Drug Product Portfolio Table 74. Vaxart, Inc Recent Development Table 75. Tekmira Pharmaceuticals Corp. Company Information Table 76. Tekmira Pharmaceuticals Corp. Business Overview Table 77. Tekmira Pharmaceuticals Corp. Marburg Hemorrhagic Fever Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Tekmira Pharmaceuticals Corp. Marburg Hemorrhagic Fever Drug Product Portfolio Table 79. Tekmira Pharmaceuticals Corp. Recent Development Table 80. Sarepta Therapeutics, Inc. Company Information Table 81. Sarepta Therapeutics, Inc. Business Overview Table 82. Sarepta Therapeutics, Inc. Marburg Hemorrhagic Fever Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Sarepta Therapeutics, Inc. Marburg Hemorrhagic Fever Drug Product Portfolio Table 84. Sarepta Therapeutics, Inc. Recent Development Table 85. Integrated BioTherapeutics, Inc. Company Information Table 86. Integrated BioTherapeutics, Inc. Business Overview Table 87. Integrated BioTherapeutics, Inc. Marburg Hemorrhagic Fever Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Integrated BioTherapeutics, Inc. Marburg Hemorrhagic Fever Drug Product Portfolio Table 89. Integrated BioTherapeutics, Inc. Recent Development Table 90. Immunovaccine, Inc. Company Information Table 91. Immunovaccine, Inc. Business Overview Table 92. Immunovaccine, Inc. Marburg Hemorrhagic Fever Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Immunovaccine, Inc. Marburg Hemorrhagic Fever Drug Product Portfolio Table 94. Immunovaccine, Inc. Recent Development Table 95. Key Raw Materials Table 96. Raw Materials Key Suppliers Table 97. Marburg Hemorrhagic Fever Drug Distributors List Table 98. Marburg Hemorrhagic Fever Drug Customers List Table 99. Research Programs/Design for This Report Table 100. Authors List of This Report Table 101. Secondary Sources Table 102. Primary Sources List of Figures Figure 1. Marburg Hemorrhagic Fever Drug Product Image Figure 2. Global Marburg Hemorrhagic Fever Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Marburg Hemorrhagic Fever Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Marburg Hemorrhagic Fever Drug Sales (2021-2032) & (K Units) Figure 5. Global Marburg Hemorrhagic Fever Drug Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Marburg Hemorrhagic Fever Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. TKM-Marburg Image Figure 9. Marburg Vaccine Image Figure 10. AVI-7288 Image Figure 11. Others Image Figure 12. Global Marburg Hemorrhagic Fever Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Marburg Hemorrhagic Fever Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Marburg Hemorrhagic Fever Drug Sales Market Share by Type (2021-2032) Figure 15. Global Marburg Hemorrhagic Fever Drug Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Marburg Hemorrhagic Fever Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Marburg Hemorrhagic Fever Drug Revenue Market Share by Type (2021-2032) Figure 18. Clinic Image Figure 19. Hospital Image Figure 20. Others Image Figure 21. Global Marburg Hemorrhagic Fever Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Marburg Hemorrhagic Fever Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Marburg Hemorrhagic Fever Drug Sales Market Share by Application (2021-2032) Figure 24. Global Marburg Hemorrhagic Fever Drug Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Marburg Hemorrhagic Fever Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Marburg Hemorrhagic Fever Drug Revenue Market Share by Application (2021-2032) Figure 27. North America Marburg Hemorrhagic Fever Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Marburg Hemorrhagic Fever Drug Sales Market Share by Country (2021-2032) Figure 29. U.S. Marburg Hemorrhagic Fever Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Marburg Hemorrhagic Fever Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Marburg Hemorrhagic Fever Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Marburg Hemorrhagic Fever Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Marburg Hemorrhagic Fever Drug Sales Market Share by Country (2021-2032) Figure 34. Germany Marburg Hemorrhagic Fever Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Marburg Hemorrhagic Fever Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Marburg Hemorrhagic Fever Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Marburg Hemorrhagic Fever Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Marburg Hemorrhagic Fever Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Marburg Hemorrhagic Fever Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Marburg Hemorrhagic Fever Drug Sales Market Share by Country (2021-2032) Figure 41. China Marburg Hemorrhagic Fever Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Marburg Hemorrhagic Fever Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Marburg Hemorrhagic Fever Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Marburg Hemorrhagic Fever Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Marburg Hemorrhagic Fever Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Marburg Hemorrhagic Fever Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Marburg Hemorrhagic Fever Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Marburg Hemorrhagic Fever Drug Sales Market Share by Country (2021-2032) Figure 49. Brazil Marburg Hemorrhagic Fever Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Marburg Hemorrhagic Fever Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Marburg Hemorrhagic Fever Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Marburg Hemorrhagic Fever Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Marburg Hemorrhagic Fever Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Marburg Hemorrhagic Fever Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Marburg Hemorrhagic Fever Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Marburg Hemorrhagic Fever Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Marburg Hemorrhagic Fever Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Marburg Hemorrhagic Fever Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Marburg Hemorrhagic Fever Drug Revenue (2021-2032) & (US$ Million) Figure 60. North America Marburg Hemorrhagic Fever Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Marburg Hemorrhagic Fever Drug Revenue (2021-2032) & (US$ Million) Figure 62. Europe Marburg Hemorrhagic Fever Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Marburg Hemorrhagic Fever Drug Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Marburg Hemorrhagic Fever Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Marburg Hemorrhagic Fever Drug Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Marburg Hemorrhagic Fever Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Marburg Hemorrhagic Fever Drug Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Marburg Hemorrhagic Fever Drug Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • TKM-Marburg
  • Marburg Vaccine
  • AVI-7288
  • Others
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • GlaxoSmithKline plc
  • Vaxart, Inc
  • Tekmira Pharmaceuticals Corp.
  • Sarepta Therapeutics, Inc.
  • Integrated BioTherapeutics, Inc.
  • Immunovaccine, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Marburg Hemorrhagic Fever Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Marburg Hemorrhagic Fever Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Marburg Hemorrhagic Fever Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Marburg Hemorrhagic Fever Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Marburg Hemorrhagic Fever Drug Market Dynamics
  1. 2.1 Marburg Hemorrhagic Fever Drug Industry Trends
  2. 2.2 Marburg Hemorrhagic Fever Drug Industry Drivers
  3. 2.3 Marburg Hemorrhagic Fever Drug Industry Opportunities and Challenges
  4. 2.4 Marburg Hemorrhagic Fever Drug Industry Restraints
3 Marburg Hemorrhagic Fever Drug Market by Manufacturers
  1. 3.1 Global Marburg Hemorrhagic Fever Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Marburg Hemorrhagic Fever Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Marburg Hemorrhagic Fever Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Marburg Hemorrhagic Fever Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Marburg Hemorrhagic Fever Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Marburg Hemorrhagic Fever Drug Manufacturers, Product Type & Application
  7. 3.7 Global Marburg Hemorrhagic Fever Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Marburg Hemorrhagic Fever Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Marburg Hemorrhagic Fever Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Marburg Hemorrhagic Fever Drug Tier 1, Tier 2, and Tier 3
4 Marburg Hemorrhagic Fever Drug Market by Type
  1. 4.1 Marburg Hemorrhagic Fever Drug Type Introduction
  2. 4.1.1 TKM-Marburg
  3. 4.1.2 Marburg Vaccine
  4. 4.1.3 AVI-7288
  5. 4.1.4 Others
  6. 4.2 Global Marburg Hemorrhagic Fever Drug Sales by Type
  7. 4.2.1 Global Marburg Hemorrhagic Fever Drug Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Marburg Hemorrhagic Fever Drug Sales by Type (2021-2032)
  9. 4.2.3 Global Marburg Hemorrhagic Fever Drug Sales Market Share by Type (2021-2032)
  10. 4.3 Global Marburg Hemorrhagic Fever Drug Revenue by Type
  11. 4.3.1 Global Marburg Hemorrhagic Fever Drug Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Marburg Hemorrhagic Fever Drug Revenue by Type (2021-2032)
  13. 4.3.3 Global Marburg Hemorrhagic Fever Drug Revenue Market Share by Type (2021-2032)
5 Marburg Hemorrhagic Fever Drug Market by Application
  1. 5.1 Marburg Hemorrhagic Fever Drug Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global Marburg Hemorrhagic Fever Drug Sales by Application
  6. 5.2.1 Global Marburg Hemorrhagic Fever Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Marburg Hemorrhagic Fever Drug Sales by Application (2021-2032)
  8. 5.2.3 Global Marburg Hemorrhagic Fever Drug Sales Market Share by Application (2021-2032)
  9. 5.3 Global Marburg Hemorrhagic Fever Drug Revenue by Application
  10. 5.3.1 Global Marburg Hemorrhagic Fever Drug Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Marburg Hemorrhagic Fever Drug Revenue by Application (2021-2032)
  12. 5.3.3 Global Marburg Hemorrhagic Fever Drug Revenue Market Share by Application (2021-2032)
6 Global Marburg Hemorrhagic Fever Drug Sales by Region
  1. 6.1 Global Marburg Hemorrhagic Fever Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Marburg Hemorrhagic Fever Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Marburg Hemorrhagic Fever Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Marburg Hemorrhagic Fever Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Marburg Hemorrhagic Fever Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Marburg Hemorrhagic Fever Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Marburg Hemorrhagic Fever Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Marburg Hemorrhagic Fever Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Marburg Hemorrhagic Fever Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Marburg Hemorrhagic Fever Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Marburg Hemorrhagic Fever Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Marburg Hemorrhagic Fever Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Marburg Hemorrhagic Fever Drug Revenue by Region
  1. 7.1 Global Marburg Hemorrhagic Fever Drug Revenue by Region
  2. 7.1.1 Global Marburg Hemorrhagic Fever Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Marburg Hemorrhagic Fever Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Marburg Hemorrhagic Fever Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Marburg Hemorrhagic Fever Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Marburg Hemorrhagic Fever Drug Revenue (2021-2032)
  8. 7.2.2 North America Marburg Hemorrhagic Fever Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Marburg Hemorrhagic Fever Drug Revenue (2021-2032)
  11. 7.3.2 Europe Marburg Hemorrhagic Fever Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Marburg Hemorrhagic Fever Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Marburg Hemorrhagic Fever Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Marburg Hemorrhagic Fever Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Marburg Hemorrhagic Fever Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 GlaxoSmithKline plc
  2. 8.1.1 GlaxoSmithKline plc Company Information
  3. 8.1.2 GlaxoSmithKline plc Business Overview
  4. 8.1.3 GlaxoSmithKline plc Marburg Hemorrhagic Fever Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 GlaxoSmithKline plc Marburg Hemorrhagic Fever Drug Product Portfolio
  6. 8.1.5 GlaxoSmithKline plc Recent Developments
  7. 8.2 Vaxart, Inc
  8. 8.2.1 Vaxart, Inc Company Information
  9. 8.2.2 Vaxart, Inc Business Overview
  10. 8.2.3 Vaxart, Inc Marburg Hemorrhagic Fever Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Vaxart, Inc Marburg Hemorrhagic Fever Drug Product Portfolio
  12. 8.2.5 Vaxart, Inc Recent Developments
  13. 8.3 Tekmira Pharmaceuticals Corp.
  14. 8.3.1 Tekmira Pharmaceuticals Corp. Company Information
  15. 8.3.2 Tekmira Pharmaceuticals Corp. Business Overview
  16. 8.3.3 Tekmira Pharmaceuticals Corp. Marburg Hemorrhagic Fever Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Tekmira Pharmaceuticals Corp. Marburg Hemorrhagic Fever Drug Product Portfolio
  18. 8.3.5 Tekmira Pharmaceuticals Corp. Recent Developments
  19. 8.4 Sarepta Therapeutics, Inc.
  20. 8.4.1 Sarepta Therapeutics, Inc. Company Information
  21. 8.4.2 Sarepta Therapeutics, Inc. Business Overview
  22. 8.4.3 Sarepta Therapeutics, Inc. Marburg Hemorrhagic Fever Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sarepta Therapeutics, Inc. Marburg Hemorrhagic Fever Drug Product Portfolio
  24. 8.4.5 Sarepta Therapeutics, Inc. Recent Developments
  25. 8.5 Integrated BioTherapeutics, Inc.
  26. 8.5.1 Integrated BioTherapeutics, Inc. Company Information
  27. 8.5.2 Integrated BioTherapeutics, Inc. Business Overview
  28. 8.5.3 Integrated BioTherapeutics, Inc. Marburg Hemorrhagic Fever Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Integrated BioTherapeutics, Inc. Marburg Hemorrhagic Fever Drug Product Portfolio
  30. 8.5.5 Integrated BioTherapeutics, Inc. Recent Developments
  31. 8.6 Immunovaccine, Inc.
  32. 8.6.1 Immunovaccine, Inc. Company Information
  33. 8.6.2 Immunovaccine, Inc. Business Overview
  34. 8.6.3 Immunovaccine, Inc. Marburg Hemorrhagic Fever Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Immunovaccine, Inc. Marburg Hemorrhagic Fever Drug Product Portfolio
  36. 8.6.5 Immunovaccine, Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Marburg Hemorrhagic Fever Drug Value Chain Analysis
  2. 9.1.1 Marburg Hemorrhagic Fever Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Marburg Hemorrhagic Fever Drug Production Mode & Process
  6. 9.2 Marburg Hemorrhagic Fever Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Marburg Hemorrhagic Fever Drug Distributors
  9. 9.2.3 Marburg Hemorrhagic Fever Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst